Insiders MEI Pharma, Inc.

Equities

Delayed Nasdaq Other stock markets 10:38:28 2024-04-30 am EDT			5-day change	1st Jan Change
3.08 ^USD	0.00%		-7.57%	-46.90%

Apr. 11	MEI Pharma, Inc. Announces Strategic Plan to Leverage Recent Positive Voruciclib and ME-344 Clinical Data	CI
Apr. 11	MEI Pharma, Inc. Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients	CI

MEI Pharma, Inc. Announces Board Changes	Nov. 01	CI
Anson Funds hires Legion Partners' Gupta to build out activism strategy	23-10-03	RE
MEI Pharma Confirms Receipt of Director Nominations from Anson Group	23-09-18	CI
Anson Group Nominates Candidates to the Board of MEI Pharma	23-09-15	CI
MEI Pharma's Finance Chief Brian Drazba to Step Down; Company Names Justin File as Successor	23-06-13	MT
MEI Pharma Names Justin File as Chief Financial Officer	23-06-13	MT
Mei Pharma, Inc. Announces Executive Changes	23-06-13	CI
MEI Pharma Promotes COO David Urso to Chief Executive	23-06-02	MT
MEI Pharma, Inc. Announces Chief Executive Officer Changes	23-06-02	CI
MEI Pharma, Inc. Announces Executive Changes	23-06-02	CI
MEI Pharma, Inc. Announces Management Changes	23-02-23	CI
MEI Pharma, Inc. Announces Management Changes	23-02-23	CI
MEI Pharma, Inc. Announces Chief Executive Officer Changes	23-02-23	CI
MEI Pharma, Inc. Announces Not Stand for Re-Election of Directors	22-10-27	CI
MEI Pharma, Inc. Announces Not Stand for Re-Election of Cheryl L. Cohen as Member of the Board of Directors	22-10-07	CI
Mei Pharma Announces Changes to Board of Directors	22-09-22	CI
MEI Pharma, Inc. Announces Board Changes	22-09-15	CI
Fate Therapeutics Appoints Brian Powl as Chief Commercial Officer	22-06-30	MT
MEI Pharma Appoints Human Resources Executive Anne Frese as Chief People Officer	22-06-22	CI
MEI Pharma, Inc. Announces New Key Executive Appointments	22-02-07	CI

No results for this search